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Commercial dosage formsAbstract Two optimized and validated spectrophotometric methods have been developed for the
determination of amiodarone hydrochloride in commercial dosage forms. Method A is based on the
reaction of tertiary amino group of the drug withN-bromosuccinimide in methanol–acetone medium
resulting in the formationofayellowcoloredproduct,whichabsorbedmaximally at353 nm.MethodB
involves the formationofa colored chloroformextractable ion-pair complexof thedrugwithbromoth-
ymol blue at pH 2.32 absorbingmaximally at 400 nm. Beer’s law is obeyed in the concentration ranges
50–600 and 2–55 lg mL1 with molar absorptivity of 1.58 · 102 and 1.50 · 104 L mol1 cm1 for
methods A and B, respectively. The regression analysis yields the calibration equations:
A= 4.012 · 104 + 1.16 · 103 C and A= 9.612 · 104 + 2.198 · 102 C for methods A and B,
respectively. The application of the proposed methods to commercial dosage forms is presented.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Amiodarone hydrochloride is a potent III antiarrhythmic drug
(Zipes et al., 1984) and is chemically known as 2-butyl-3-ben-
zofuranyl 4-[2-(diethyl amino) ethoxy]-3,5-diidophenyl metha-
none hydrochloride. It is used to treat ventricular and
supraventricular arrhythmias, especially when they are resis-
tant to other conventional antiarrhythmic drugs (Levy, 1988;
Mason, 1987). The drug is ofﬁcially listed in The British
26 N. Rahman et al.Pharmacopoeia (2009) and describes the potentiometric titra-
tion for the assay of amiodarone HCl.
The analytical techniques that have been utilized for the
quantiﬁcation of this drug in biological ﬂuids and pharmaceu-
tical formulations include high performance liquid chromatog-
raphy (Rodrigues et al., 2013; Al Riyami, 2010; Khan et al.,
2005; Cervelli et al., 1981; Brien et al., 1983; Flanagan et al.,
1985; Hug et al., 1991; Vio and Mamoto, 1998), high perfor-
mance thin layer chromatography (Yang and Fang, 1995), li-
quid chromatography (Gupta and Connelly, 1984; Geoffriau
et al., 1992), infrared spectroscopy (Jensen et al., 1988), Ra-
man spectroscopy (Orkoula et al., 2007), ﬂuorescence spectros-
copy (Mohamed et al., 1998), enzyme linked immunosorbent
assay and electrochemical methods (Saita et al., 2002; Ball
et al., 1996). The literature survey revealed that only few spec-
trophotometric methods are available for its quantiﬁcation. A
spectrophotometric method was presented for the assay of
amiodarone based on reaction of the drug with citric acid–ace-
tic anhydride (Rao and Sastry, 2002) reagent to provide a blu-
ish-violet color having an absorption maximum at 580 nm.
However, Beer’s law was obeyed over the concentration range
2–12 lg mL1 but required 45 min to complete the analysis.
Amiodarone was found to form insoluble molecular complexes
with iodine, ammonium molybdate (AM) or phosphomolybdic
acid (PMA) (Rao et al., 2002) under acid conditions and spec-
trophotometric methods were developed based on the color
formation with either unreacted precipitant in the ﬁltrate (I2)
or released precipitant form the precipitate (AM or PMA) with
chromogenic reagents. However, these methods are tedious to
perform and time consuming. Extractive spectrophotometric
methods have also been developed based on chloroform
extractable ion-association complex (Rao et al., 2001) of the
drug with tropaeolin 00, tropaeolin 000, or wool fast blue.
Amiodarone was also determined spectrophotometrically
using the charge transfer complexation reaction of the drug
with p-chloronilic acid and 2,3-dichloro 5,6-dicyano 1,4-
benzoquinone (Rahman et al., 2004), and chloranil and iodine
(Ebeid et al., 1998). Spectrophotometry is the technique of
choice even today due to its low cost, inherent simplicity and
adaptability (Czegan and Hoover, 2012). It has wide applica-
tion in the quantitative analysis of pharmaceutical drugs in
clinical and pharmaceutical laboratories.
The present paper describes two simple and accurate spec-
trophotometric methods for the assay of amiodarone hydro-
chloride in bulk and commercial dosage forms. Method A is
based on bromination of drug with N-bromosuccinimide
whereas method B utilizes chloroform extractable ion-associa-
tion complex of drug with bromothymol blue (BTB). The reac-
tion conditions of the proposed methods are thoroughly
studied, optimized and validated as per the International Con-
ference on Harmonisation (ICH, 1995).
2. Experimental
2.1. Apparatus
The absorbance measurements were made on a Spectronic
20D+ Spectrophotometer (Milton Roy Company, USA) with
1 cm matched glass cells. A water bath shaker (Narang Scien-
tiﬁc Works Pvt. Limited, New Delhi, India) was used to con-
trol the temperature.2.2. Reagents and marketed tablets
Amiodarone hydrochloride was kindly provided by Troikaa
Pharmaceutical Ltd. India and was used as received. Commer-
cial dosage forms of amiodarone hydrochloride such as Duron
(Samarth Pharma Pvt. Ltd., India), Cardarone (Sanoﬁ Synthe-
labo (India) Ltd.) and Amiodar (Cardicare, India) were pur-
chased from local drug stores, labeled to contain 100 mg
amiodarone hydrochloride per tablet.
 N-bromosuccinimide (1.12 · 101 M; S.d. ﬁne Chem. Ltd.,
India) solution was prepared in acetone.
 Bromothymol blue (4.01 · 104 M, Loba chemie Pvt. Ltd.,
India) solution was prepared in distilled water.
 Sodium acetate-hydrochloric acid buffer of pH 2.32 was
prepared by mixing 50 mL of 1.0 M sodium acetate solution
with 51 mL of 1.0 M HCl and diluted to 250 mL with dis-
tilled water (Britton, 1942).2.3. Test solutions
 Amiodarone hydrochloride (1 mg mL1) solution was pre-
pared in methanol for method A.
 Amiodarone hydrochloride (0.5 mg mL1) solution was
prepared in chloroform for method B.2.4. Proposed procedures for the determination of amiodarone
hydrochloride
2.4.1. Method A
Aliquots of standard solution of amiodarone hydrochloride
(1 mg mL1) equivalent to 0.25–3.0 mg were transferred
into a series of boiling tubes. To each tube, 1.7 mL of
1.12 · 101 M N-bromosuccinimide was added and the con-
tents were heated on a water bath at 40 ± 1 C for 10 min.
After cooling at room temperature, the contents were trans-
ferred to a 5 mL volumetric ﬂask and the volume was completed
up to the mark with methanol. The absorbance of the colored
product was measured at kmax = 353 nm against the reagent
blank prepared similarly except amiodarone. The calibration
curve was plotted and regression equation was developed.
2.4.2. Method B
Into a series of 50 mL separating funnels, 5 mL of buffer solu-
tion of pH 2.32 and 5 mL of BTB were placed. An appropriate
volume (0.04–1.1 mL) of amiodarone hydrochloride
(0.5 mg mL1) was added to each funnel and mixed well.
The funnels were shaken vigorously with 10 mL chloroform
for 2 min, and then allowed to stand for clear separation of
two phases. The absorbance of the organic phase was mea-
sured at kmax = 400 nm against the reagent blank prepared
simultaneously.
2.5. Determination of amiodarone hydrochloride in commercial
dosage forms
Ten tablets were powdered and mixed thoroughly. For method
A, an amount of the tablet powder equivalent to 100 mg of
amiodarone hydrochloride was weighed accurately and ex-
tracted into 50 mL methanol with shaking. Filtration through
Whatmann No. 42 ﬁlter paper was performed. The ﬁltrate was
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Figure 1 Bent and French stoichiometric plot of (a) amiodarone
hydrochloride and (b) N-bromosuccinimide for method A.
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Figure 2 Absorption spectrum of amiodarone hydrochloride
(50.0 lg mL1) + 3.5 mL of 4.01 · 104 M BTB + 5.0 mL of
sodium acetate–HCl buffer solution of pH 2.32 for method B.
The solution is extracted in 10 mL chloroform for absorption
spectrum of the ion-pair complex.
0.5
0.6
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the tablet powder equivalent to 100 mg amiodarone hydro-
chloride was stirred well with chloroform and ﬁltered through
Whatmann No. 42 ﬁlter paper. The ﬁltrate and washings were
diluted to volume in a 100 mL volumetric ﬂask. The assay was
completed following the proposed procedures.
2.6. Evaluation of bias
The bias has been evaluated by means of point and interval
hypothesis tests (Hartmann et al., 1995; Canada Health Pro-
tection Branch, 1992). In interval hypothesis the proposed
method is accepted when the true mean is within ± 2% of that
of the true reference method (method 1), i.e.,
0:02 l1 < ðl2  l1Þ < 0:02 l1
The above equation can also be written as:
0:98 < l2=l1 < 1:02
which can be generalized toO
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Scheme I Reaction sequence of method A.hL < l2=l1 < hu
where hL and hU are lower and upper acceptance limits, respec-
tively. The limits of this conﬁdence interval can be calculated
as the two roots of the following quadratic equation.
h2 x21  S2pt2tab=n1
 
 2hx1x2 þ x22  S2pt2tab=n2
 
¼ 0Mole ratio [N-bromosuccinimide] / [Amiodarone hydrochloride]
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Figure 3 Mole ratio plot for stoichiometric ratio between
amiodarone hydrochloride and N-bromosuccinimide
(1.10 · 102 M each) for method A.
Figure 4 FTIR spectra of (a) amiodarone hydrochloride (b) bromothymol blue and (c) amiodarone–bromothymol blue complex.
28 N. Rahman et al.where Sp is the pooled standard deviation and ttab is the stu-
dent’s t-value at the given conﬁdence level.3. Results and discussion
N-bromosuccinimide is an extremely useful and a versatile re-
agent (Barakat and Mousa, 1952). Its unique brominating abil-
ity has been attributed to its almost non-polar N-bromine
bond, as well as the favorable geometric arrangement, which
exists between the N-bromine and carbonyl function. It hasbeen reported (Dunstan and Henbest, 1957) that tertiary
amine reacts with N-bromosuccinimide resulting in the forma-
tion of colored intermediate, which on hydrolysis yields alde-
hydes and brominated secondary amine whereas N-
bromosuccinimide is irreversibly reduced to succinimide. This
can be expressed as:
ðR CH2Þ3Nþ BrNðCOCH2Þ2
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tertiary amino group, which reacts quantitatively with N-bro-
mosuccinimide in methanol–acetone medium resulting in the
formation of a colored product absorbing maximally at
353 nm. The stoichiometry of the reaction was studied adopt-
ing the limiting logarithmic method (Bent and French, 1941).
The absorbance of the reaction product was alternatively mea-
sured in the presence of excess of N-bromosuccinimide and
amiodarone hydrochloride. A plot of log absorbance vs. log
[N-bromosuccinimide] and log [amiodarone hydrochloride]
gave straight lines; the values of the slopes were 1.05 and
1.00, respectively (Fig. 1). It is concluded that the reaction pro-
ceeds in the ratio of 1:1. Based on the obtained molar reactiv-
ity, the reaction pathway is shown in Scheme I.
At pH 2.32, the amino group of amiodarone is protonated
while the sulfonic acid group present in BTB is undergoing dis-
sociation. The color of BTB is due to the opening of the lactoid
ring and subsequent formation of the quinoid group. It is sup-
posed that the two tautomers are present in equilibrium but
due to strong acidic nature of the sulfonic acid group, the quin-
oid body must predominate. Finally, the protonated amioda-
rone forms an ion-pair with BTB, which is quantitativelyextracted into chloroform. The ion-pair complex absorbed
maximally at 400 nm and the reagent blank under similar con-
ditions showed no absorption at the speciﬁed wavelength. The
absorption spectrum is shown in (Fig. 2). The stoichiometry
was established by the mole ratio method (Sawyer et al.,
1984). As can be seen from Fig. 3 that the molar ratio of
amiodarone to BTB was 1:1. The FTIR spectra of amiodarone
hydrochloride, bromothymol blue and amiodarone-bromothy-
mol blue ion pair are shown in Fig. 4a–c. In the FTIR
spectrum of amiodarone hydrochloride, stretching vibrations
of –C‚O, –C–O–C–, N–H+ and C–N occurred at 1630,
1244, 2365 and 1173 cm1, respectively (Socrates, 1980). The
FTIR spectrum of bromothymol blue exhibited bands at
1196 cm1 and 1025 cm1 which are assigned to –SO3 group
(Silverstein and Webster, 2005). The band appearing at
656 cm1 is due to C–Br stretching vibrations. The FTIR spec-
trum of the amiodarone–bromothymol blue ion pair complex
showed the bands due to the stretching vibrations of –C‚O,
C–O–C, N–H+, C–N, SO3– and C–Br groups, thus conﬁrming
the formation of the ion pair complex extractable into chloro-
form. On the basis of our experimental ﬁndings and literature
background, the reaction sequence is shown in Scheme II.
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Figure 5 Effect of heating time on the absorbance of color
reaction between amiodarone hydrochloride and N-bromosuccin-
imide for method A.
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Figure 7 Effect of pH: 50.0 lg mL1 amiodarone hydrochlo-
ride + 5.0 mL of sodium acetate–HCl buffer solution of different
pH+ 3.5 mL of 4.01 · 104 M BTB (Method B).
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The optimum conditions for the assay procedures (methods A
and B) have been established by studying the reactions as a
function of heating time, concentration of reagents, pH and
nature of solvent.
3.1.1. Method A
3.1.1.1. Effect of heating time. To investigate the optimum
heating time for color development, aliquots of amiodaroneVolume of 1.12 x 10−1 M N-Bromosuccinimide (mL)
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Figure 6 Effect of the volume of 1.12 · 101 M N-bromosuc-
cinimide on the absorbance of yellow product (600.0 lg mL1
amiodarone hydrochloride).hydrochloride (3 mg) were transferred into a series of boiling
tubes. To each tube, 2 mL of 1.12 · 101 M N-bromosuccini-
mide was added followed by 5 mL of methanol. The tubes were
placed on a waterbath maintained at 40 ± 1 C for different
time intervals. The results are shown in Fig. 5. As can be seen
from Fig. 4 that the maximum absorbance was obtained at
8 min and remained constant up to 12 min. Therefore,
10 min heating time was used throughout the experiment.Volume of 4.0 x 10-4 M bromothymol blue (mL)
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Figure 8 Effect of the volume of 4.01 · 104 M BTB on the
absorbance of the ion pair complex (50.0 lg mL1 amiodarone
hydrochloride; 5.0 mL of buffer solution of pH 2.32).
Table 1 Test of precision of the proposed methods.
Proposed methods Concentration (lg mL1) Recovery RSD SAEb CLc
Taken Found ± SDa (%) (%)
Method A
Intraday assay 160 159.98 ± 0.15 99.99 0.09 0.07 0.18
360 359.99 ± 0.14 99.99 0.04 0.06 0.17
560 560.02 ± 0.13 100.00 0.02 0.06 0.16
Interday assay 160 159.99 ± 0.22 100.00 0.14 0.01 0.27
360 359.96 ± 0.20 99.99 0.06 0.09 0.25
560 559.98 ± 0.18 100.00 0.03 0.08 0.22
Method B
Intraday assay 5 5.01 ± 0.08 100.18 1.49 0.03 0.09
25 25.00 ± 0.06 100.02 0.25 0.03 0.08
50 49.99 ± 0.07 99.99 0.14 0.03 0.09
Interday assay 5 5.01 ± 0.10 100.18 2.07 0.05 0.13
25 25.00 ± 0.09 100.03 0.38 0.04 0.12
50 49.99 ± 0.10 99.99 0.20 0.05 0.13
a Mean for ﬁve independent analysis.
b SAE, standard analytical error.
c CL, conﬁdence limit at 95% conﬁdence level and 4 degrees of freedom (t= 2.776).
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ence of the volume of 1.12 · 101 M N-bromosuccinimide on
the color development was examined in the range of 0.1–
2.0 mL. The highest absorbance was obtained with 1.5 mL,
which remained unchanged with higher amount of N-bromo-
succinimide (Fig. 6). Thus, 2.0 mL of the reagent was selected
as an optimum value for the determination process.
3.1.2. Method B
3.1.2.1. Effect of the pH. The inﬂuence of pH on the ion-pair
formation between amiodarone and BTB was studied using a
sodium acetate-hydrochloric acid buffer in the pH range ofTable 2 Standard addition technique for the determination of amio
Formulations Concentration, (lg mL1)
Nominal Added
Method A
Cardarone 100 80 80
(Sanoﬁ Synthelabo) 80 160
Duron 100 80 80
(Samarth Pharma) 80 160
Amiodar 100 80 80
(Cardicare) 80 160
Method B
Cardarone 100 15 20
(Sanoﬁ Synthelabo) 15 40
Duron 100 15 20
(Samarth Pharma) 15 40
Amiodar 100 15 20
(Cardicare) 15 40
a Mean for ﬁve independent analysis.
b SAE, standard analytical error.
c CL, conﬁdence limit at 95% conﬁdence level and 4 degrees of freedo1.4–3.3 .The results are shown in Fig. 7. It was observed that
the maximum and constant absorbance was found between
pH 1.99 and 2.64. Thus, a buffer of pH 2.32 was used in fur-
ther studies.
3.1.2.2. Effect of bromothymol blue concentration. The effect of
the volume of 4.01 · 104 M BTB was studied in the range of
0.5–5.0 mL. The maximum absorbance was found with 3 mL
of BTB; above this volume the absorbance remained un-
changed (Fig. 8). Thus, 3.5 mL of BTB was used for the ion-
pair formation throughout the experiment.darone hydochloride in dosage forms.
SAEb CLc
Found ± SDa
159.93 ± 0.15 0.07 0.19
239.91 ± 0.14 0.06 0.17
160.02 ± 0.17 0.07 0.21
240.03 ± 0.20 0.09 0.25
160.03 ± 0.13 0.06 0.16
240.03 ± 0.13 0.06 0.16
35.03 ± 0.10 0.05 0.13
55.01 ± 0.09 0.04 0.11
35.01 ± 0.04 0.02 0.05
55.02 ± 0.05 0.02 0.07
35.01 ± 0.05 0.02 0.06
55.02 ± 0.05 0.02 0.07
m (t= 2.776).
Table 3 Spectrophotometric determination of amiodarone hydrochloride in synthetic mixture samples by proposed methods A and B.
Synthetic samples Method A Method B
Concentration (lg mL1) Recovery Concentration (lg mL1) Recovery
Taken Found (%) Taken Found (%)
a1 600.00 600.06 100.01 30.00 29.99 99.66
b2 400.00 399.00 99.75 50.00 50.02 100.04
a Amiodarone hydrochloride (100 mg) with colloidal silicon dioxide (50 mg), lactose monohydrate (50 mg), magnesium stearate (30 mg),
povidone (20 mg), starch (50 mg) and FD & C Red 40 (5 mg).
b Amiodarone hydrochloride (50 mg) with colloidal silicon dioxide (50 mg), lactose monohydrate (50 mg), magnesium stearate (20 mg), maize
starch (25 mg), povidone (15 mg) and talc (30 mg).
32 N. Rahman et al.3.1.2.3. Choice of organic solvent and time of shaking. A variety
of organic solvents such as benzene, toluene, hexane, chloro-
form, ethyl acetate, carbon tetrachloride and 1,2-dichloro-
methane were examined for extraction of the ion-pair.
However chloroform was preferred owing to selective extrac-
tion of the ion-pair complex from the aqueous solution.
The time of shaking for complete extraction of the ion-pair
complex was studied in the range of 0.5–4 min. It was found
that the absorbance remained constant over this time period.
Thus, 2 min shaking time was used as an optimum value
throughout the experiment.Table 4 Applicability of the proposed spectrophotometric method f
dosage forms by the proposed methods and the reference method.
Formulations Nominal Content Content found
(lg mL1) (lg mL1)
Method A
aCardarone 100 600.00 600.06
(Sanoﬁ Synthelabo) hL = 0.986
t= 0.022
bDuron 100 600.00 600.06
(Samarth Pharma) hL = 0.991
t= 0.033
cAmiodar 100 600.00 600.06
(Cardicare) hL = 0.985
t= 0.002
Method B
aCardarone 100 50.00 50.00
(Sanoﬁ Synthelabo) hL = 0.988
t= 0.012
bDuron 100 50.00 50.04
(Samarth Pharma) hL = 0.987
t= 0.189
cAmiodar 100 50.00 50.02
(Cardicare) hL = 0.987
t= 0.111
a Cordorone 100 has the following excipients: colloidal silicon dioxide,
FD and C Red 40.
b Duron 100 has the excipients such as: silica colloidal anhydrous, cro
povidone and talc.
c The excipients of amiodar 100 are: colloidal silicon dioxide, lactose m3.2. Linearity, limits of detection and quantitation
Under the optimized experimental conditions, the absorbance-
concentration plots were found to be linear over the concentra-
tion ranges 50–600 lg mL1 and 2–55 lg mL1 of amiodarone
hydrochloride with molar absorptivity of 1.58 · 102 and
1.50 · 104 L mol1cm1 for methods A and B, respectively.
The linear regression analysis of calibration data gave the fol-
lowing equations:
A ¼ 4:012 104 þ 1:16 103C
r ¼ 0:9999 for method Aor the determination of amiodarone hydrochloride in commercial
RSD Reference method
(%) Content found
(lg mL1)
RSD (%)
0.02 599.4 0.02
hu = 1.014
F= 1.04
0.02 599.4 0.02
hu = 1.008
F= 1.36
0.02 600.06 0.02
hu = 1.015
F= 1.18
0.12 49.95 0.14
hu = 1.012
F= 1.38
0.13 49.95 0.14
hu = 1.011
F= 1.22
0.13 50.00 0.03
hu = 1.012
F= 1.18
lactose monohydrate, magnesium stearate, povidone, corn starch and
spovidone lactose monohydrate, magnesium stearate, maize starch,
onohydrate, maize starch, povidone and talc.
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r ¼ 0:9999 for method B
where A is the absorbance, C is the concentration in lg mL1
and r is the correlation coefﬁcient. The values of conﬁdence
limit at 95% conﬁdence level for slopes were found to be
1.16 · 103 ± 6.87 · 106 and 2.198 · 102 ± 4.07 · 104
whereas for intercepts of calibration lines were
4.012 · 104 ± 2.41 · 103 and 9.612 · 104 ± 1.33 · 103
for methods A and B, respectively. The good linearity of the
calibration graphs and the negligible scatter of the experimen-
tal points were clearly evident from the values of correlation
coefﬁcient and variance of calibration lines (3.24 · 106 and
1.06 · 106 lg mL1 for methods A and B, respectively). Test
of signiﬁcance for intercepts of the regression lines was per-
formed. For this, the values of t- were calculated using the rela-
tion t= a/S (Nalimov, 1963) and found to be 0.393 and 1.705
for methods A and B, respectively which did not exceed the
tabulated t-value (t= 2.367, m= 7) at 95% conﬁdence level.
It conﬁrmed that the intercepts for the proposed methods
are not signiﬁcantly different from zero.
The limits of detection for methods A and B were calcu-
lated and found to be 5.12 and 0.16 lg mL1, while the limits
of quantitation were 15.52 and 0.50 lg mL1, respectively.
3.3. Accuracy and precision
The within day precision was evaluated through replicate anal-
ysis (n= 5) of quality control samples: 160, 360 andTable 5 Comparison of the proposed spectrophotometric methods
in pharmaceutical formulations.
Reagents kmax, nm Molar absorptivi
l mol1 cm1
Spectrophometry: p-
chloranilic acid
535 1.42 · 103
2,3-Dichloro-5,6-dicyanao-
1,4-benzoquinone
570 7.50 · 103
Extractive spectrophometry:
Tropaeolin 00
420 –
Tropaeolin 000 480 –
Wool fast blue 580 –
Cobalt thiocyanate 620 –
Fluorimetry: Native
ﬂuorescence in 0.1 N sulfuric
acid medium
HPLC: Mobile phase: Buﬀer
solution of pH 5: methanol:
acetonitrile (3:3:4, v/v/v)
UV detector 240 –
Capillary electrophoresis UV detector 240 –
Spectrophometry: method A
(N-bromosuccimide)
353 1.58 · 102
Extractive spectrophometry:
method B (bromothymol
blue)
400 1.50 · 104560 lg mL1 for method A and 5, 25 and 50 lg mL1 for
method B. The percentage recoveries ranged from 99.99 to
100.00 with % RSD from 0.02% to 0.09% and 99.99% to
100.18% with RSD from 0.14% to 1.49% for methods A
and B, respectively. The interday precision was also evaluated
through replicate analysis of the quality control samples for
ﬁve consecutive days at the same concentration levels as used
in within day precision. The percentage recoveries for methods
A and B ranged from 99.99% to 100.00% with RSD from
0.03% to 0.14% and 99.99% to 100.18% with RSD from
0.20% to 2.07%, respectively (Table 1). The results in Table 1
indicate high precision of the proposed methods. The selectiv-
ity of the proposed methods was investigated by observing any
interference encountered from the excipients of the tablets such
as magnesium stearate, talc, lactose, starch and gelatin. It was
observed that these excipients did not interfere with the pro-
posed methods.
The standard addition method was applied to check the
validity of the proposed methods for the determination of ami-
odarone hydrochloride in commercial tablets (Table 2). The
synthetic mixture samples of amiodarone hydrochloride were
prepared and analyzed for % recovery of amiodarone hydro-
chloride. The results are summarized in Table 3. The percent-
age recoveries were in the range of 99.66–100.04% for methods
A and B. This study has further conﬁrmed that the common
excipients present in tablet formulations did not interfere with
the assay.
The proposed methods were applied to the determination
of amiodarone hydrochloride in commercial tablets such aswith existing related techniques for the assay of amiodarone HCl
ty, Linear dynamic
range, lg mL1
RSD, % Reference
10–360 0.11–0.91 Rahman et al. Rahman
et al. (2004)
2–65 0.16–1.48 Rahman et al. Rahman
et al. (2004)
2.5–15 – Rao et al. Rao et al.
(2001)
3–30 – Rao et al. Rao et al.
(2001)
0.75–7.5 – Rao et al. Rao et al.
(2001)
25–300 – Rao et al. Rao et al.
(2001)
40–200 Mohamed et al.
Mohamed et al. (1998)
5–15 – Al Riyami (2010)
0.004–0.1 – Zhang and Thormann
Zhang and Thormann
(1996)
10–360 0.03–0.14 This work
2–55 0.2–2.07 This work
34 N. Rahman et al.Duron, Amiodar and Cardarone. The same batch of commer-
cial dosage forms was also analyzed by the reference method
(Rahman et al., 2004). The results of the proposed methods
were compared with those obtained by the reference method.
Statistical analysis of the results using Student’s t-test, variance
ratio F-test and interval hypothesis test (Christian, 1994) re-
vealed no signiﬁcant difference between the proposed method
(A or B) and the reference method at 95% conﬁdence level
regarding accuracy and precision. The results are summarized
in Table 4. When the proposed methods are compared with
other methods for determining amiodarone hydrochloride in
pharmaceuticals (Table 5) it can be seen that their sensitivity
is higher than most of the compared methods. Only methods
with sample preconcentration (Al Riyami, 2010; Zhang and
Thormann, 1996) yielded a higher sensitivity but the instru-
mental set-up is much more complex and expensive.
4. Conclusion
The proposed methods are quite selective as the drug contains
a basic centre, which preferentially interacts with N-bromosuc-
cinimide and bromothymol blue. Both the methods show no
interference from the common excipients and additives. The
statistical parameters and recovery data reveal good accuracy
and precision of the proposed methods. Therefore, it is con-
cluded that the proposed methods are simple, sensitive and ra-
pid for the determination of amiodarone hydrochloride in pure
form and commercial tablets.Acknowledgements
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